StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note published on Monday morning. The firm issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Price Performance
BTX opened at $0.95 on Monday. The business has a fifty day simple moving average of $1.41 and a 200 day simple moving average of $1.75. Brooklyn ImmunoTherapeutics has a 1 year low of $0.17 and a 1 year high of $10.10. The company has a market capitalization of $55.89 million, a PE ratio of -0.40 and a beta of 4.61.
Brooklyn ImmunoTherapeutics Company Profile
See Also
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- There Are Different Types of Stock To Invest In
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.